Log in

NYSE:STESteris Stock Price, Forecast & News

-1.76 (-1.13 %)
(As of 08/7/2020 04:00 PM ET)
Today's Range
Now: $154.22
50-Day Range
MA: $154.93
52-Week Range
Now: $154.22
Volume498,659 shs
Average Volume410,252 shs
Market Capitalization$13.10 billion
P/E Ratio32.06
Dividend Yield0.95%
STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions. It also provides capital equipment install, maintain, upgrade, repair, and troubleshoot services. This segment provides its products and services to acute care hospitals, ambulatory surgery centers, and GI clinics. The Healthcare Specialty Services segment provides solutions and managed services, including instrument and endoscope repair and maintenance solutions; and custom process improvement consulting and outsourced sterile processing services to acute care hospitals and other healthcare settings. The Life Sciences segment offers formulated cleaning chemistries, barrier products, sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. The Applied Sterilization Technologies segment provides contract sterilization services using gamma, electron beam, and X-ray technologies, as well as ethylene oxide and hydrogen peroxide; and laboratory testing services. It operates a network of approximately 50 facilities. The company was founded in 1985 and is based in Derby, the United Kingdom.
Read More
Steris logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.3Community Rank: 2.1Dividend Strength: 3.3Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.88 out of 5 stars

Industry, Sector and Symbol

Industry Surgical appliances & supplies
Sub-IndustryHealth Care Equipment



Sales & Book Value

Annual Sales$3.03 billion
Cash Flow$7.92 per share
Book Value$41.08 per share


Net Income$407.61 million


Market Cap$13.10 billion
Next Earnings Date11/2/2020 (Estimated)
-1.76 (-1.13 %)
(As of 08/7/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive STE News and Ratings via Email

Sign-up to receive the latest news and ratings for STE and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Steris (NYSE:STE) Frequently Asked Questions

How has Steris' stock been impacted by COVID-19 (Coronavirus)?

Steris' stock was trading at $145.25 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, STE shares have increased by 6.2% and is now trading at $154.22.
View which stocks have been most impacted by Coronavirus

Do Wall Street analysts recommend investors buy shares of Steris?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Steris in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Steris

When is Steris' next earnings date?

Steris is scheduled to release its next quarterly earnings announcement on Monday, November 2nd 2020.
View our earnings forecast for Steris

How were Steris' earnings last quarter?

Steris PLC (NYSE:STE) issued its earnings results on Monday, August, 3rd. The medical equipment provider reported $1.31 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.98 by $0.33. The medical equipment provider earned $668.90 million during the quarter, compared to the consensus estimate of $643.38 million. Steris had a net margin of 13.69% and a return on equity of 16.24%. Steris's revenue was down 4.0% on a year-over-year basis. During the same period last year, the business earned $1.23 earnings per share.
View Steris' earnings history

How often does Steris pay dividends? What is the dividend yield for Steris?

Steris announced a quarterly dividend on Monday, August 3rd. Shareholders of record on Thursday, August 27th will be given a dividend of $0.40 per share on Thursday, September 24th. This represents a $1.60 annualized dividend and a dividend yield of 1.04%. The ex-dividend date of this dividend is Wednesday, August 26th. This is an increase from Steris's previous quarterly dividend of $0.37.
View Steris' dividend history

What price target have analysts set for STE?

3 brokerages have issued 12-month price targets for Steris' stock. Their forecasts range from $170.00 to $170.00. On average, they anticipate Steris' share price to reach $170.00 in the next year. This suggests a possible upside of 10.2% from the stock's current price.
View analysts' price targets for Steris

Has Steris been receiving favorable news coverage?

News articles about STE stock have trended very negative recently, according to InfoTrie Sentiment. The research group ranks the sentiment of news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Steris earned a news impact score of -3.4 on InfoTrie's scale. They also gave headlines about the medical equipment provider a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the near future.
View the latest news about Steris

Are investors shorting Steris?

Steris saw a decline in short interest during the month of July. As of July 31st, there was short interest totaling 855,500 shares, a decline of 6.2% from the July 15th total of 911,800 shares. Based on an average daily trading volume, of 564,000 shares, the short-interest ratio is presently 1.5 days. Currently, 1.0% of the shares of the company are sold short.
View Steris' Short Interest

Who are some of Steris' key competitors?

What other stocks do shareholders of Steris own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Steris investors own include Johnson & Johnson (JNJ), Pfizer (PFE), AbbVie (ABBV), Home Depot (HD), Mastercard (MA), AT&T (T), Abbott Laboratories (ABT), Cisco Systems (CSCO), Gilead Sciences (GILD) and Mcdonald's (MCD).

Who are Steris' key executives?

Steris' management team includes the following people:
  • Mr. Walter M. Rosebrough Jr., CEO & Pres (Age 65)
  • Mr. Michael J. Tokich, Sr. VP, CFO & Director (Age 50)
  • Mr. Daniel A. Carestio, Chief Operating Officer (Age 46)
  • Mr. John Adam Zangerle, Sr. VP, Gen. Counsel, Sec. & Director (Age 52)
  • Dr. Adrian Vincent Coward, Sr. VP of Healthcare Specialty Services (Age 49)

What is Steris' stock symbol?

Steris trades on the New York Stock Exchange (NYSE) under the ticker symbol "STE."

Who are Steris' major shareholders?

Steris' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Bessemer Group Inc. (1.09%), Principal Financial Group Inc. (0.91%), Fisher Asset Management LLC (0.79%), Congress Asset Management Co. MA (0.74%), Villere ST Denis J & Co. LLC (0.72%) and Alta Capital Management LLC (0.59%). Company insiders that own Steris stock include Cary L Majors, Cynthia L Feldmann, Daniel A Carestio, Jacqueline B Kosecoff, John Adam Zangerle, Karen L Burton, Kathleen Bardwell, Loyal W Wilson, Michael B Wood, Michael J Tokich, Mohsen Sohi, Renato Tamaro, Richard Martin Steeves, Walter M Rosebrough Jr and Walter M Rosebrough, Jr.
View institutional ownership trends for Steris

Which major investors are selling Steris stock?

STE stock was sold by a variety of institutional investors in the last quarter, including Fisher Asset Management LLC, Assenagon Asset Management S.A., Robeco Institutional Asset Management B.V., Frontier Capital Management Co. LLC, GW&K Investment Management LLC, New York State Common Retirement Fund, Arizona State Retirement System, and WINTON GROUP Ltd. Company insiders that have sold Steris company stock in the last year include John Adam Zangerle, Mohsen Sohi, Renato Tamaro, and Richard Martin Steeves.
View insider buying and selling activity for Steris

Which major investors are buying Steris stock?

STE stock was purchased by a variety of institutional investors in the last quarter, including TimesSquare Capital Management LLC, Retirement Systems of Alabama, Principal Financial Group Inc., Bessemer Group Inc., Alta Capital Management LLC, McCollum Christoferson Group LLC, Princeton Portfolio Strategies Group LLC, and Envestnet Asset Management Inc..
View insider buying and selling activity for Steris

How do I buy shares of Steris?

Shares of STE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Steris' stock price today?

One share of STE stock can currently be purchased for approximately $154.22.

How big of a company is Steris?

Steris has a market capitalization of $13.10 billion and generates $3.03 billion in revenue each year. The medical equipment provider earns $407.61 million in net income (profit) each year or $5.64 on an earnings per share basis. Steris employs 13,000 workers across the globe.

What is Steris' official website?

The official website for Steris is www.steris.com.

How can I contact Steris?

Steris' mailing address is 70 Sir John Rogerson`s Quay, Dublin L2, D02 R296. The medical equipment provider can be reached via phone at 353-1232-2000 or via email at [email protected]

This page was last updated on 8/9/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.